2/24
07:53 am
otlk
Rating for OTLK
Low
Report
Rating for OTLK
2/18
08:00 am
otlk
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $3.00 price target on the stock.
Medium
Report
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $3.00 price target on the stock.
2/18
05:56 am
otlk
Rating for OTLK
Medium
Report
Rating for OTLK
1/17
09:17 am
otlk
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
Medium
Report
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
1/17
09:17 am
otlk
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
Medium
Report
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
1/17
09:14 am
otlk
Rating for OTLK
Medium
Report
Rating for OTLK
1/17
09:14 am
otlk
Rating for OTLK
Medium
Report
Rating for OTLK
1/17
07:56 am
otlk
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.